Arbios Logo   Contact UsPatients/CliniciansSite Map  
About Arbios Liver Disease Product Pipeline Investor/Media Relations  
  News & EventsStock InfoSEC FIlings  
Stock Chart Investor/Media Relations  
Stock Chart

 

 

 

 

 

Press Releases

ARBIOS TO PRESENT AT BIO 2006 CHICAGO ANNUAL INTERNATIONAL CONVENTION

Presentation Scheduled for Tuesday, April 11th at 9:00am Central Time

WALTHAM, MASSACHUSETTS – April 10, 2006 -- Arbios Systems, Inc. (OTC: ABOS) a biomedical device and cell therapy company developing proprietary liver assist products for the treatment of liver failure, today announced that Walter Ogier, President and Chief Executive Officer of Arbios Systems, is scheduled to present at the BIO 2006 Chicago Annual International Convention to be held at the McCormick Place Convention Center, Chicago, on Tuesday, April 11, 2006 at 9:00 a.m. CST.  Mr. Ogier will provide a corporate overview and update at the Business Forum in Level 3, Hall A, Room A.

Arbios Systems, Inc. is a publicly traded medical device and cell therapy company based in Massachusetts and in California that is engaged in the discovery, acquisition and development of proprietary liver assist devices and new technologies useful in the diagnosis and treatment of liver failure.  Arbios’ products in development include SEPET™, a novel blood purification therapy and HepatAssist™, a bioartificial liver combining liver cell therapy and device-based detoxification.  For further information on the Company, access the website at http://www.arbios.com.

Return To Top

space

 

 

   
         
 

About Arbios | Liver Disease | Product Pipeline | Investor/Media Relations | Site Map | Home | Contact Us | Terms of Use